Literature DB >> 21350981

Anti-inflammatory properties of doxycycline and minocycline in experimental models: an in vivo and in vitro comparative study.

Liz M Leite1, Antônio Germano G Carvalho, Pollyanna L F Tavares Ferreira, Igor Xavier Pessoa, Danilo O Gonçalves, Amanda de Araújo Lopes, Jean Guilherme dos Santos Góes, Victor Costa de Castro Alves, Luzia Kalyne A M Leal, Gerly Anne Brito, Glauce S B Viana.   

Abstract

AIMS AND METHODS: Minocycline (Mino) and doxycycline (Dox) are second generation tetracyclines known to present several other effects, which are independent from their antimicrobial activities. We studied in a comparative way the anti-inflammatory effects of Mino and Dox, on acute models of peripheral inflammation in rodents (formalin test and peritonitis in mice, and carrageenan-induced paw oedema in rats). Immunohistochemical assays for TNF-alpha and iNOS in rat paws of carrageenan-induced oedema were also carried out as well as in vitro assays for myeloperoxidase (MPO) and lactate dehydrogenase (LDH). Furthermore, antioxidant activities were evaluated by the DPPH assay.
RESULTS: In the formalin test although Mino and Dox (1, 5, 10 and 25 mg/kg, i.p.) inhibited the first phase, they acted predominantly on the second phase of the test, where inhibition of the licking time close to 80% were observed. Mino and Dox were very efficacious in reducing the carrageenan-induced paw oedema in rats (10, 25 and 50 mg/kg, i.p.) and carrageenan-induced leucocyte migration (1 and 5 mg/kg, i.p.) to mice peritoneal cavities. Besides, they also significantly inhibited MPO and LDH releases at doses ranging from 0.001 to 1 μg/ml. Thus, in general, the anti-inflammatory activity of Dox was higher as compared to that of Mino, although the radical scavenging activity of Mino was of a magnitude 10 times higher.
CONCLUSIONS: Our data indicate that anti-inflammatory and antioxidant effects, involve the inhibition of iNOS and TNF-alpha, among other properties, and these encourage clinical studies of these compounds for new therapeutic applications, especially those were inflammation plays a role.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21350981     DOI: 10.1007/s10787-011-0077-5

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  49 in total

1.  Minocycline attenuates T cell and microglia activity to impair cytokine production in T cell-microglia interaction.

Authors:  Fabrizio Giuliani; Walter Hader; V Wee Yong
Journal:  J Leukoc Biol       Date:  2005-04-07       Impact factor: 4.962

2.  Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation.

Authors:  Annemarie Ledeboer; Evan M Sloane; Erin D Milligan; Matthew G Frank; John H Mahony; Steven F Maier; Linda R Watkins
Journal:  Pain       Date:  2005-05       Impact factor: 6.961

3.  Minocycline inhibits cytochrome c release and delays progression of amyotrophic lateral sclerosis in mice.

Authors:  Shan Zhu; Irina G Stavrovskaya; Martin Drozda; Betty Y S Kim; Victor Ona; Mingwei Li; Satinder Sarang; Allen S Liu; Dean M Hartley; Du Chu Wu; Steven Gullans; Robert J Ferrante; Serge Przedborski; Bruce S Kristal; Robert M Friedlander
Journal:  Nature       Date:  2002-05-02       Impact factor: 49.962

4.  [Effect of doxycycline on inflammation-related cytokines and apoptosis in human conjunctival epithelial cells].

Authors:  Qi-guo Xiao; Zu-guo Liu; Mei Zhang; Jian-liang Zheng; Zhi-hong Zhang; Li-hui Luo; Jia-qi Chen
Journal:  Zhonghua Yan Ke Za Zhi       Date:  2005-09

5.  Systemic administration of minocycline inhibits formalin-induced inflammatory pain in rat.

Authors:  Ik-Hyun Cho; Young Min Chung; Chul-Kyu Park; Seong-Hae Park; Haeyeong Lee; Hai Ying Li; Donghoon Kim; Zheng Gen Piao; Se-Young Choi; Sung Joong Lee; Kyungpyo Park; Joong Soo Kim; Sung Jun Jung; Seog Bae Oh
Journal:  Brain Res       Date:  2006-01-19       Impact factor: 3.252

6.  The tetracycline analogs minocycline and doxycycline inhibit angiogenesis in vitro by a non-metalloproteinase-dependent mechanism.

Authors:  S Gilbertson-Beadling; E A Powers; M Stamp-Cole; P S Scott; T L Wallace; J Copeland; G Petzold; M Mitchell; S Ledbetter; R Poorman
Journal:  Cancer Chemother Pharmacol       Date:  1995       Impact factor: 3.333

7.  Early short-term treatment with doxycycline modulates postinfarction left ventricular remodeling.

Authors:  Francisco J Villarreal; Michael Griffin; Jeffrey Omens; Wolfgang Dillmann; Judy Nguyen; James Covell
Journal:  Circulation       Date:  2003-09-02       Impact factor: 29.690

8.  Carrageenan-induced paw edema in rat elicits a predominant prostaglandin E2 (PGE2) response in the central nervous system associated with the induction of microsomal PGE2 synthase-1.

Authors:  Jocelyne Guay; Kevin Bateman; Robert Gordon; Joseph Mancini; Denis Riendeau
Journal:  J Biol Chem       Date:  2004-03-24       Impact factor: 5.157

9.  The synovial prostaglandin system in chronic inflammatory arthritis: differential effects of steroidal and nonsteroidal anti-inflammatory drugs.

Authors:  S Bombardieri; P Cattani; G Ciabattoni; O Di Munno; G Pasero; C Patrono; E Pinca; F Pugliese
Journal:  Br J Pharmacol       Date:  1981-08       Impact factor: 8.739

10.  Improved outcome of EAN, an animal model of GBS, through amelioration of peripheral and central inflammation by minocycline.

Authors:  Zhi-Yuan Zhang; Zhiren Zhang; Uwe Fauser; Hermann J Schluesener
Journal:  J Cell Mol Med       Date:  2008-04-08       Impact factor: 5.310

View more
  29 in total

1.  Gastroprotective effect of minocycline in experimentally induced gastric ulcers in rats.

Authors:  Abdulrahman Al Asmari; Saud Al Omani; Malfi Al Otaibi; Abdul-Aziz Al Abdulaaly; Ibrahim Elfaki; Khalid Al Yahya; Mohammed Arshaduddin
Journal:  Int J Clin Exp Med       Date:  2014-03-15

Review 2.  Similarities and differences between doxycycline and minocycline: clinical and antimicrobial stewardship considerations.

Authors:  B A Cunha; J Baron; C B Cunha
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2017-08-17       Impact factor: 3.267

3.  Preclinical trial on the use of doxycycline for the treatment of adenocarcinoma of the duodenum.

Authors:  Hector R Galván-Salazar; Alejandro D Soriano-Hernández; Daniel A Montes-Galindo; Gabriel Ceja Espíritu; José Guzman-Esquivel; Iram P Rodríguez-Sánchez; Oscar A Newton-Sánchez; Margarita L Martinez-Fierro; Xóchitl G Briseño Gómez; Augusto Rojas-Martínez; Iván Delgado-Enciso
Journal:  Mol Clin Oncol       Date:  2016-09-08

Review 4.  Minocycline: therapeutic potential in psychiatry.

Authors:  Olivia M Dean; João Data-Franco; Francesco Giorlando; Michael Berk
Journal:  CNS Drugs       Date:  2012-05-01       Impact factor: 5.749

5.  Protective effect of doxycycline on germinal epithelial loss caused by a high-fat diet.

Authors:  Ivan Delgado-Enciso; Alejandro García-Rivera; M Violeta M Madrigal-Pérez; Alejandrina Rodriguez-Hernandez; Agustin Lugo-Radillo; Hector R Galvan-Salazar; Alejandro D Soriano-Hernández; Fernando Gómez-Tapia; Rafael Martinez-Martinez; Laura L Valdez-Velazquez; Oscar A Newton-Sanchez; Rafael Gonzalez-Alvarez; Iram P Rodriguez-Sanchez; Valery Melnikov; Agustin Lara-Esqueda; Jose Guzman-Esquivel
Journal:  Int Urol Nephrol       Date:  2013-11-28       Impact factor: 2.370

6.  In vitro study of matrix metalloproteinases 1, 2, 9, 13 and serum amyloid A mRNAs expression in equine fibroblast-like synoviocytes treated with doxycycline.

Authors:  Samaneh Ghasemi; Kamran Sardari; Pezhman Mirshokraei; Hossein Hassanpour
Journal:  Can J Vet Res       Date:  2018-04       Impact factor: 1.310

Review 7.  Lyme neuroborreliosis-epidemiology, diagnosis and management.

Authors:  Uwe Koedel; Volker Fingerle; Hans-Walter Pfister
Journal:  Nat Rev Neurol       Date:  2015-07-28       Impact factor: 42.937

8.  Minocycline inhibits peritoneal macrophages but activates alveolar macrophages in acute pancreatitis.

Authors:  Laia Bonjoch; Sabrina Gea-Sorlí; Joaquin Jordan; Daniel Closa
Journal:  J Physiol Biochem       Date:  2015-11-11       Impact factor: 4.158

9.  Locally delivered minocycline microspheres do not impair osseointegration of titanium implants in a rat femur model.

Authors:  Joshua A Shapiro; Samuel AbuMoussa; Christopher P Lindsay; Gabriel B Mason; Laurence E Dahners; Paul S Weinhold
Journal:  J Orthop       Date:  2019-12-12

10.  Minocycline microspheres did not significantly improve outcomes after collagenase injection of tendon.

Authors:  Andrew D Allen; Alex M Bassil; David J Berkoff; Mohammed Al Maliki; Reid W Draeger; Paul S Weinhold
Journal:  J Orthop       Date:  2019-06-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.